Literature DB >> 11726229

CTLA-4 gene polymorphisms in Tunisian patients with Graves' disease.

H Hadj Kacem1, M Bellassoued, N Bougacha-Elleuch, M Abid, H Ayadi.   

Abstract

Graves' disease (GD) is an organ-specific autoimmune disorder of multifactorial etiology with a polygenic mode of inheritance. A recent report has demonstrated that there is a linkage and an association between the genetic markers of the CTLA-4 gene on chromosome 2q33 and GD. In order to confirm this association in a Tunisian population, three polymorphisms of the CTLA-4 gene were analyzed: the first is at the -318 position from the ATG start codon consisting of a C/T change; the second is in position 49 of exon 1, which lies in the A/G transition; and the third is in the 3' untranslated region with variant lengths of the dinucleotide (AT)n repeat. The genomic DNA from 144 patients with GD and 205 healthy individuals was genotyped after specific polymerase chain reaction amplification. Comparative analysis using a chi(2) test showed a weak yet significant difference in allele frequencies of the A/G dimorphic marker between patients and controls (P < 0.05), and a significant increase of A/A homozygous individuals among patients (21.53 vs 12.7%, P = 0.02, odds ratio (OR) = 1.89) was found. Analyses of CTLA-4 A/G polymorphism with respect to sex showed a significant difference in A/A genotypes between female patients and controls (OR = 2.14; 95%, 1.13 < OR < 4.04, P < 0.05). The distribution of CTLA-4 (AT)n allele frequencies differed between patients and controls (chi(2) = 38.18, 20 degrees of freedom, P = 0.0084) and the highest OR was found with the CTLA-4 (AT)-224-bp allele (OR = 6.43, 1.7 < OR < 28.64; P = 0.001). In conclusion, these results show that the CTLA-4 gene, or one closely associated with it, confers susceptibility to GD in a Tunisian population. (c)2001 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11726229     DOI: 10.1006/clim.2001.5121

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  9 in total

1.  Natural evolution of hepatitis C virus infection in hemodialysis Tunisian patients and CTLA-4 SNP's.

Authors:  Leila Ksiaa Cheikhrouhou; Yousr Lakhoua-Gorgi; Imen Sfar; Salwa Jendoubi-Ayed; Houda Aouadi; Mouna Makhlouf; Khaled Ayed; Taieb Ben Abdallah
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

2.  A Study on the Level of T(3), T(4), TSH and the Association of A/G Polymorphism with CTLA-4 Gene in Graves' Hyperthyroidism among South Indian Population.

Authors:  P Veeramuthumari; W Isabel; K Kannan
Journal:  Indian J Clin Biochem       Date:  2010-12-29

3.  Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene.

Authors:  Qin Zhang; Yun-mei Yang; Xue-ying Lv
Journal:  J Zhejiang Univ Sci B       Date:  2006-11       Impact factor: 3.066

4.  Association and gene-gene interaction analyses for polymorphic variants in CTLA-4 and FOXP3 genes: role in susceptibility to autoimmune thyroid disease.

Authors:  Nusrath Fathima; Parimala Narne; Mohammed Ishaq
Journal:  Endocrine       Date:  2019-02-15       Impact factor: 3.633

5.  Association between rs3087243 and rs231775 polymorphism within the cytotoxic T-lymphocyte antigen 4 gene and Graves' disease: a case/control study combined with meta-analyses.

Authors:  Yaqin Tu; Guorun Fan; Yu Dai; Tianshu Zeng; Fei Xiao; Lulu Chen; Wen Kong
Journal:  Oncotarget       Date:  2017-11-27

6.  Association between the CTLA-4 +49A/G polymorphism and Graves' disease: A meta-analysis.

Authors:  Xiaoyu Si; Xiufeng Zhang; Wenru Tang; Ying Luo
Journal:  Exp Ther Med       Date:  2012-06-20       Impact factor: 2.447

7.  The predictive value of CTLA-4 and Tg polymorphisms in the recurrence of Graves' disease after antithyroid withdrawal.

Authors:  Sevda Tanrikulu; Yeşim Erbil; Evin Ademoglu; Halim Işsever; Umut Barbaros; Faruk Kutlutürk; Selçuk Ozarmagan; Serdar Tezelman
Journal:  Endocrine       Date:  2006-12       Impact factor: 3.925

8.  CTLA-4 +49A/G and CT60 gene polymorphisms in primary Sjögren syndrome.

Authors:  Jacques-Eric Gottenberg; Pascale Loiseau; Mariam Azarian; Chun Chen; Nicolas Cagnard; Eric Hachulla; Xavier Puechal; Jean Sibilia; Dominique Charron; Xavier Mariette; Corinne Miceli-Richard
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

9.  Chromosome 2q33genetic polymorphisms in Tunisian endemic pemphigus foliaceus.

Authors:  Olfa Abida; Emna Bahloul; Mariem Ben Jmaa; Khadija Sellami; Ferjani Zouidi; Raouia Fakhfakh; Nadia Mahfoudh; Hamida Turki; Hatem Masmoudi
Journal:  Mol Genet Genomic Med       Date:  2020-09-01       Impact factor: 2.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.